Tags

Type your tag names separated by a space and hit enter

Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?

Abstract

Family history is a significant risk factor for developing pancreatic cancer and this hereditary risk can be secondary to familial cancer predisposition syndromes, hereditary pancreatitis, or familial pancreatic cancer. Certain high-risk individuals are recommended to undergo screening for pancreatic cancer with endoscopic ultrasound or MRI/magnetic resonance retrograde cholangiopancreatography because of the potential to identify and curatively resect precursor lesions. The management of suspicious lesions identified on screening high-risk individuals is also discussed.

Links

  • Publisher Full Text
  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Surgery, University of Colorado, 12631 East 17th Avenue, C-302, Aurora, CO 80045, USA.

    Department of Surgery, University of Colorado, 12631 East 17th Avenue, C-302, Aurora, CO 80045, USA. Electronic address: richard.schulick@ucdenver.edu.

    Source

    MeSH

    Carcinoma
    Early Detection of Cancer
    Genetic Predisposition to Disease
    Genetic Testing
    Humans
    Incidence
    Neoplastic Syndromes, Hereditary
    Pancreatic Neoplasms
    Risk Assessment
    United States

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    29191275

    Citation

    Torphy, Robert J., and Richard D. Schulick. "Screening of Patients at Risk for Familial Pancreatic Cancer: what Is Beneficial?" The Surgical Clinics of North America, vol. 98, no. 1, 2018, pp. 25-35.
    Torphy RJ, Schulick RD. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? Surg Clin North Am. 2018;98(1):25-35.
    Torphy, R. J., & Schulick, R. D. (2018). Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? The Surgical Clinics of North America, 98(1), pp. 25-35. doi:10.1016/j.suc.2017.09.003.
    Torphy RJ, Schulick RD. Screening of Patients at Risk for Familial Pancreatic Cancer: what Is Beneficial. Surg Clin North Am. 2018;98(1):25-35. PubMed PMID: 29191275.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? AU - Torphy,Robert J, AU - Schulick,Richard D, PY - 2017/12/2/entrez PY - 2017/12/2/pubmed PY - 2017/12/12/medline KW - Familial pancreatic cancer KW - High-risk individuals KW - Pancreatic cancer KW - Screening KW - Surveillance SP - 25 EP - 35 JF - The Surgical clinics of North America JO - Surg. Clin. North Am. VL - 98 IS - 1 N2 - Family history is a significant risk factor for developing pancreatic cancer and this hereditary risk can be secondary to familial cancer predisposition syndromes, hereditary pancreatitis, or familial pancreatic cancer. Certain high-risk individuals are recommended to undergo screening for pancreatic cancer with endoscopic ultrasound or MRI/magnetic resonance retrograde cholangiopancreatography because of the potential to identify and curatively resect precursor lesions. The management of suspicious lesions identified on screening high-risk individuals is also discussed. SN - 1558-3171 UR - https://www.unboundmedicine.com/medline/citation/29191275/Screening_of_Patients_at_Risk_for_Familial_Pancreatic_Cancer:_What_Is_Beneficial L2 - https://linkinghub.elsevier.com/retrieve/pii/S0039-6109(17)30139-1 DB - PRIME DP - Unbound Medicine ER -